Filing Details
- Accession Number:
- 0001628280-25-016742
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-04 13:37:13
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-04-04
- Accepted Time:
- 2025-04-04 13:37:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 1600 West End Ave. Suite 1300 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-03 | 10 | $5.54 | 5,698,748 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-04 | 10 | $5.11 | 5,698,758 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-05 | 10 | $6.75 | 5,698,768 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-06 | 10 | $6.57 | 5,698,778 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-07 | 10 | $6.51 | 5,698,788 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-10 | 7 | $5.85 | 5,698,795 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-11 | 7 | $4.85 | 5,698,802 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-12 | 7 | $5.17 | 5,698,809 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-13 | 7 | $5.47 | 5,698,816 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-14 | 7 | $5.38 | 5,698,823 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-17 | 7 | $5.41 | 5,698,830 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-18 | 7 | $5.12 | 5,698,837 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-19 | 7 | $5.41 | 5,698,844 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-20 | 7 | $5.07 | 5,698,851 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-21 | 7 | $4.89 | 5,698,858 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-24 | 8 | $4.42 | 5,698,866 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-25 | 8 | $4.45 | 5,698,874 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-26 | 8 | $4.41 | 5,698,882 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-27 | 8 | $4.20 | 5,698,890 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-28 | 8 | $4.20 | 5,698,898 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-31 | 8 | $4.29 | 5,698,906 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
